This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ready or Not, Health Care Reform Is Coming

By Kevin Grewal, editorial director at

At a time when President Obama's approval ratings are declining, the nation's economy is still struggling and it appears that nothing is really happening in Washington to ignite a much-needed spark to boost consumer confidence, a health care bill in some form will have to pass.

The largest obstacle that the pending overhaul of the health care system is facing is cost. In a nutshell, the president wants to curb costs while expanding health insurance coverage to many of the 46 million uninsured Americans, which has a trillion dollar price tag attached with it.

On the one side, some are arguing that a government-run health care option would place stiff competition on private insurers, which could potentially be detrimental to the insurance industry and the employer-based insurance model used by the majority of Americans.

On the other side, critics are stating that the reform does not have enough cost savings involved with it. One big part of the proposed reform includes a piece that would have Medicare and insurance companies cut nearly 5% of the nation's annual medical bill by refusing to pay for care for complications due to doctor or hospital error.

Many believe that the reform is focused on narrower issues such as taxing medical benefits and cutting hospital prices and is overlooking the quality issue, which in the long run will be the most cost effective.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
VHT $114.54 -1.80%
XLV $63.77 -0.98%
UNH $110.09 -1.50%
THC $24.15 -6.80%
AAPL $95.01 1.05%


Chart of I:DJI
DOW 16,027.05 -177.92 -1.10%
S&P 500 1,853.44 -26.61 -1.42%
NASDAQ 4,283.7530 -79.3910 -1.82%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs